Mark G. Eller - Net Worth and Insider Trading

Mark G. Eller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark G. Eller owns 1 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) .

Click here to see the complete history of Mark G. Eller’s form 4 insider trades.

Insider Ownership Summary of Mark G. Eller

Ticker	Comapny	Transaction Date	Type of Owner
JAZZ	Jazz Pharmaceuticals PLC	2011-02-08	SVP & Research & Clinical Dev.

Mark G. Eller Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark G. Eller Ownership Network

Ownership Network List of Mark G. Eller

No Data

Ownership Network Relation of Mark G. Eller

Mark G. Eller Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Mark G. Eller is the SVP & Research & Clinical Dev. of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include director & Executive Chairman Bruce C Cozadd , SVP & Technical Operations Mary Elizabeth Henderson , and VP & Finance& PAO Patricia Carr .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Mark G. Eller made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Mark Douglas Smith .

In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Mark G. Eller Mailing Address

Above is the net worth, insider trading, and ownership report for Mark G. Eller. You might contact Mark G. Eller via mailing address: C/o Jazz Pharmaceuticals, Inc., 3180 Porter Drive, Palo Alto Ca 94304.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.